KAT5 and Kaposi's sarcoma: However, we have only tested the effect of Tip60 inhibitors on KSHV-positive PEL cells; thus, it would be advantageous to also examine the effect of Tip60 inhibitors on KS, which remains the second most common cancer in HIV-infected patients worldwide (Gbabe et al., 2014).